- 全部删除
您的购物车当前为空
SB-649868 (GSK649868) 是一种有效的选择性口服活性食欲素拮抗剂,对 OX1 和 OX2 受体的 pKi 分别为 9.4 和 9.5。


为众多的药物研发团队赋能,
让新药发现更简单!
SB-649868 (GSK649868) 是一种有效的选择性口服活性食欲素拮抗剂,对 OX1 和 OX2 受体的 pKi 分别为 9.4 和 9.5。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 286 | In stock | |
| 5 mg | ¥ 696 | In stock | |
| 10 mg | ¥ 1,190 | In stock | |
| 25 mg | ¥ 2,530 | In stock | |
| 50 mg | ¥ 3,520 | In stock | |
| 100 mg | ¥ 4,750 | In stock | |
| 200 mg | ¥ 6,530 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 822 | In stock |
SB-649868 相关产品
| 产品描述 | SB-649868 (GSK649868) is a potent and selective orally active antagonist of orexin(pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively). |
| 靶点活性 | OX1:9.4 (pKi), OX2:9.5 (pKi) |
| 体外活性 | SB-649868 antagonizes orexin-A-induced inositol 1 phosphate (IP1) accumulation with the following pKB value (OX1=9.67;?OX2=9.64).?SB-649868 displaces the [3H]ACT-078573 receptor binding with the following pKi values: OX1=9.27;?OX2=8.91.?Increasing concentrations of SB-649868 (0.3 nM-30 nM) induces a rightward shift of the orexin-A CRCs with a depression of the agonist efficacy suggesting a clear non-surmountable behavior.?The calculated apparent pKb values are 9.67 0.03 and 9.64 0.07 for OX1 and OX2 |
| 别名 | GSK649868 |
| 分子量 | 477.55 |
| 分子式 | C26H24FN3O3S |
| CAS No. | 380899-24-1 |
| Smiles | Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(s1)-c1ccc(F)cc1 |
| 密度 | 1.305 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (209.40 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容